The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Dietary Supplementation with 20-Hydroxyecdysone Ameliorates Hepatic Steatosis and Reduces White Adipose Tissue Mass in Ovariectomized Rats Fed a High-Fat, High-Fructose Diet
Open accessAbstract
Metabolic dysfunction-associated fatty liver disease (MAFLD) is defined as hepatic steatosis in combination with overweight, diabetes, or other metabolic risk factors. MAFLD affects a significant number of the global population and imposes substantial clinical and economic burdens. With no approved pharmacotherapy, current treatment options are limited to diet and exercise. Therefore, the development of medicines for MAFLD treatment or prevention is necessary. 20-Hydroxyecdysone (20E) is a natural steroid found in edible plants and has been shown to improve metabolism and dyslipidemia. Therefore, it may be useful for MAFLD treatment. Here, we aimed to determine how dietary supplementation with 20E affects fat accumulation and lipogenesis in the liver and adipose tissue of ovariectomized rats fed a high-fat, high-fructose diet (OHFFD). We found that 20E reduced hepatic triglyceride content and visceral fat deposition. 20E increased the phosphorylation of AMP-activated protein kinase and acetyl CoA carboxylase while reducing the expression of fatty acid synthase in the liver and adipose tissue. Additionally, 20E increased hepatic expression of carnitine palmitoyltransferase-1 and reduced adipose expression of sterol regulatory element-binding protein-1. In conclusion, 20E demonstrated beneficial effects in rats with OHFFD-induced MAFLD. These findings suggest that 20E may represent a promising option for MAFLD prevention or treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Dietary supplementation of 20E in OHFFD increased the phosphorylation of AMPK and acetyl-CoA carboxylase while reducing the expression of fatty acid synthase in liver and adipose tissue.”
From Molecular Targets of 20-Hydroxyecdysone in Mammals, Mechanism of Action: Is It a Calorie Restriction Mimetic and Anti-Aging Compound? (2025) · cites this paper as [90]
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, 20E also increased expression of carnitine palmitoyltransferase-1 in the liver and reduced expression of sterol regulatory element-binding protein-1 in adipose tissue.”
From Molecular Targets of 20-Hydroxyecdysone in Mammals, Mechanism of Action: Is It a Calorie Restriction Mimetic and Anti-Aging Compound? (2025) · cites this paper as [90]
The cited source says what the claim attributes to it.
In the citing paper
“The above alterations decreased fatty acid biosynthesis and lipogenesis and increased lipolysis/beta-oxidation; therefore, 20E ameliorated hepatic steatosis combined with overweight, diabetes, or other metabolic risk factors, and this was achieved without altering calorie intake in OHFFD rats [90].”
From Molecular Targets of 20-Hydroxyecdysone in Mammals, Mechanism of Action: Is It a Calorie Restriction Mimetic and Anti-Aging Compound? (2025) · cites this paper as [90]
The cited source says what the claim attributes to it.
In the citing paper
“In liver hepatocytes, 20E inhibits FAS in vivo; meanwhile, it promotes fatty acid degradation [90], showing the opposite response to that of myoblasts and fibroblasts in vitro [96].”
From Molecular Targets of 20-Hydroxyecdysone in Mammals, Mechanism of Action: Is It a Calorie Restriction Mimetic and Anti-Aging Compound? (2025) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s009 · Cited by 1,555
The Emergence of the Metabolic Syndrome with Menopause
Carr, M. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030242 · Cited by 1,449
Angiogenesis and Inflammation in Peritoneal Dialysis: The Role of Adipocytes
Shi, J., Yu, M., & Sheng, M. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000476017 · Cited by 1,403
Cited by
Zádor, E. (2025) · Cells · doi:10.3390/cells14060431 · Cited by 9
“Since 20E appears to act on both mitochondrial function [59,106] and fat metabolism [67,70,74,75,90], it is an intriguing question if it can influence fat browning.”
InfluentialCerulli, A., Polcaro, L. M., Masullo, M., & Piacente, S. (2024) · Foods · doi:10.3390/foods13223699 · Cited by 6
Abdelmoneim, D., Eldomany, E., El‐Adl, M., Farghali, A. A., El‐Sayed, G., & Said, E. S. E. S. E. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03495-9 · Cited by 10
Ma, Q., Wu, F., Liu, X., Zhao, C., Sun, Y., Li, Y., Zhang, W., Ju, H., & Wang, Y. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.101958 · Cited by 5
Sripinyowanich, S., Denben, B., Satapoomin, P., Tumnark, P., & Phoemsapthawee, J. (2025) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.71.526
Metadata
- Authors
- Buniam, J., Chansela, P., Weerachayaphorn, J., & Saengsirisuwan, V.
- Affiliations
- Chulabhorn Royal Academy (TH)
- Phramongkutklao College of Medicine (TH)
- Mahidol University (TH)
- Corresponding author
- Saengsirisuwan, Vitoon
- Venue
- Biomedicines
- Publisher
- MDPI AG
- Published
- 2023-07-23
- Volume
- 11
- Issue
- 7
- Pages
- 2071
- ISSN
- 2227-9059 (ISSN-L)
- PMC
- PMC10377470
- OpenAlex
- W4385201650
- Cited by
- 9
- References
- 60
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 3
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomedicines (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Mahidol University (640200017397000)
- Chulabhorn Royal Academy (640200017397000)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- 20-hydroxyecdysone, non-alcoholic fatty liver disease, hepatic steatosis, white adipose tissue, high-fat high-fructose diet, ovariectomy, AMPK, acetyl-CoA carboxylase, fatty acid synthase, carnitine palmitoyltransferase 1, SREBP1, lipogenesis, dietary supplementation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dietary Supplementation with 20-Hydroxyecdysone Ameliorates Hepatic Steatosis and Reduces White Adipose Tissue Mass in Ovariectomized Rats Fed a High-Fat, High-Fructose Diet. https://app.cochat.ai/papers/10.3390/biomedicines11072071
- The paper
- Buniam, J., Chansela, P., Weerachayaphorn, J., & Saengsirisuwan, V. (2023). Dietary Supplementation with 20-Hydroxyecdysone Ameliorates Hepatic Steatosis and Reduces White Adipose Tissue Mass in Ovariectomized Rats Fed a High-Fat, High-Fructose Diet. Biomedicines. https://doi.org/10.3390/biomedicines11072071
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.